Piramal Buys Selected Pfizer OTCs To Pursue Market Leader Goal

The consumer goods arm of Piramal Enterprises has just made its third acquisition in six months, keeping up a hectic deal-making pace in its quest to be one of India’s leading OTC players.

Cash-flush Piramal Enterprises Ltd., the flagship company of Indian pharma tycoon Ajay Pharma's Piramal Group, has taken another step toward its goal of being a top-three player in India’s over-the-counter business by buying four popular brands from Pfizer Inc. for INR1.1bn ($16.4m).

More from Focus On Asia

More from Scrip